The Consumer Justice Foundation Alerts the Public of a Meeting of an FDA Advisory Panel Discussing the Potential Risks of Topamax Side Effects Due to Safety Concerns

Share Article

The Consumer Justice Foundation, a for-profit corporation that provides free online resources for consumers that allow them to remain informed with regards to issues relating to the dangers of pharmaceutical medications including the URL http://www.topamaxbirthinjury.com, hereby discusses a recent meeting of an FDA Advisory Panel that came together to discuss the potential dangers of Topamax side effects in the form of Topamax birth defects present in children of mothers who used this medication while they were pregnant. These FDA advisory panels often meet to move towards a decision regarding whether the marketing of a medication should be restricted.

The Consumer Justice Foundation, a for-profit corporation that’s comprised of a team of professional consumer advocates who publish free online resources for consumers that are intended to alert them to the dangers of using certain prescription medications, hereby discuss a recent meeting of an FDA Advisory Panel that met to discuss the potential dangers of Topamax side effects that appear in the form of Topamax birth defects in children whose mothers used this medication during the early stages of pregnancy. These dangers included those faced by mothers who were dealing with teen pregnancy. These FDA panel discussions are part of the investigative process that takes place for medications that are allegedly dangerous to the public.

The FDA Advisory Panel met on September 23 met to discuss several pieces of information regarding alleged Topamax side effects that include cleft lip and cleft palate, otherwise known as oral cleft. The panel reviewed the results of a Risk Evaluation and Mitigation Strategy (REMS) regarding cleft lip and/or cleft palate when infants were exposed to Topamax that was approved in March of 2011.

The panel also reviewed the labeling on the containers of Topamax that state that infants exposed in utero to Topamax have an increased risk of cleft lip and/or cleft palate. The results of this panel discussion, which is meant to help decide whether or not the risks of allowing Topamax to remain on the market as compared to the benefits of allowing people to continue to use it, have not yet been released.

Topamax is manufactured by Ortho-McNeil Pharmaceutical, which is a subsidiary of Johnson & Johnson, was originally approved by the FDA for treatment of epilepsy in 1996 and also approved in 2004 for the treatment of migraine headaches. The medication has been linked to several different Topamax side effects that include those mentioned above.

About the Consumer Justice Foundation

The Consumer Justice Foundation, whose Web site can be found at http://www.topamaxbirthinjury.com, is a for-profit organization that serves two purposes for consumers: (1) to provide educational information regarding the policies and procedures of large corporations and how they affect the average consumer; and (2) to provide news updates and resources that continue to update consumers regarding developments taken by corporations that include pharmaceutical drug companies, auto manufacturers and insurance companies so that consumers who have been harmed can use these informational resources to connect to an experienced professional who can help them. The team at the Consumer Justice Foundation is staffed by experienced and passionate consumer advocates whose mission is to raise the awareness of issues that could pose a risk of harm to those who may not otherwise be aware of the dangers they face.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Faith Anderson
Visit website